Beyond GOG-258 and PORTEC-3: a national cancer database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer

被引：0
|
作者：
Lander, Megan [1 ]
Vargo, John [1 ]
Sukumvanich, Paniti [1 ]
机构：
[1] Univ Pittsburgh, Gynecol Oncol, Magee Womens Hosp, Med Ctr, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.252
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV133/#547
引用
收藏
页码：A154 / A154
页数：1
相关论文
共 50 条
  • [21] Combined modality adjuvant therapy for high-risk endometrial cancer
    Vanderstichele, Adriaan
    Neven, Patrick
    Vergote, Ignace
    LANCET ONCOLOGY, 2016, 17 (08): : 1029 - 1030
  • [22] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Carinelli, Silvestro
    Provencher, Diane
    Hanzen, Chantal
    Lutgens, Ludy C. H. W.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    D'Amico, Romerai
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2018, 19 (03): : 295 - 309
  • [23] Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Kruitwagen, Roy F.
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2016, 17 (08): : 1114 - 1126
  • [24] TERTIARY LYMPHOID STRUCTURES AS MARKERS OF ANTI-TUMOR IMMUNITY WITH INDEPENDENT PROGNOSTIC VALUE IN THE PORTEC-3 TRIAL OF HIGH-RISK ENDOMETRIAL CANCER
    Horeweg, N.
    Workel, H.
    Loiero, D.
    Church, D.
    Vermij, L.
    Leon-Castillo, A.
    De Boer, S.
    Nout, R.
    Powell, M.
    Mileshkin, L.
    Mackay, H.
    Leary, A.
    Singh, N.
    Jurgenliemk-Schulz, I.
    Creutzberg, C. L.
    Kolzer, V.
    Nijman, H. W.
    Bosse, T.
    De Bruyn, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A99 - A101
  • [25] Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis
    Gupta, Vishal
    McGunigal, Mary
    Prasad-Hayes, Monica
    Kalir, Tamara
    Liu, Jerry
    GYNECOLOGIC ONCOLOGY, 2017, 144 (01) : 119 - 124
  • [26] Disease free survival and overall survival in patients with high-risk endometrial cancer receiving adjuvant therapy in England
    Ralphs, E.
    Prabhu, V. S.
    Teoh, C.
    Macey, K.
    Ridsdale-Smith, J.
    Landfeldt, E.
    Trankov, N.
    Litchfield, J.
    Eminowicz, G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 58 - 58
  • [27] National Evaluation of the Predictors of Compliance and Survival from Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A National Cancer Database (NCDB) Analysis
    de Paula, Thais Reif
    Simon, Hillary
    da Luz, Magda Maria Profeta
    Keller, Deborah S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E103 - E104
  • [28] A national evaluation of the predictors of compliance and survival from adjuvant chemotherapy in high-risk stage II colon cancer: A National Cancer Database (NCDB) analysis
    de Paula, Thais Reif
    Gorroochurn, Prakash
    Haas, Eric M.
    Keller, Deborah S.
    SURGERY, 2022, 172 (03) : 859 - 868
  • [29] Utilization and Survival Benefit of Adjuvant Immunotherapy in Resected High-Risk Stage II Melanoma: A National Cancer Database Analysis
    Wong, W. G.
    Olecki, E.
    Stahl, K.
    Holguin, R. Perez
    Pameijer, C.
    Shen, C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S27 - S27
  • [30] Treatment Outcomes and Toxicity Profiles with PORTEC-3 Trial Regimen in South Asian Cohort of High-Risk Endometrial Cancer Patients: A Single-Center Ambispective Analysis
    Verma, Parth
    Rajan, Rajasree
    Sasidharan, Ajay
    Kalavagunta, Sruthi
    Dutta, Debnarayan
    Kunheri, Beena
    Kunnath, Neethu
    Bhati, Priya
    Rajanbabu, Anupama
    Nair, Indu
    Puthenveedu, Rakesh Moolayil
    Haridas, Nikhil
    Jose, Wesley
    Pavithran, Keechilat
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
12345